{"id":47743,"date":"2022-08-29T13:02:08","date_gmt":"2022-08-29T11:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/"},"modified":"2022-08-29T13:02:08","modified_gmt":"2022-08-29T11:02:08","slug":"levine-leichtman-capital-partners-sells-monte-nido","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/","title":{"rendered":"Levine Leichtman Capital Partners Sells Monte Nido"},"content":{"rendered":"
\n

LOS ANGELES–(BUSINESS WIRE)–Levine Leichtman Capital Partners (\u201cLLCP\u201d), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company Monte Nido & Affiliates (\u201cMonte Nido\u201d or the \u201cCompany\u201d) to funds managed by Revelstoke Capital Partners LLC. Financial terms of the transaction were not disclosed.\n<\/p>\n

\nFounded in 1996, Monte Nido is a leading provider of treatment programs and services to adults and adolescents with eating disorders. The Company operates five respected brands with over 45 facilities across the U.S. that provide a continuum of care encompassing inpatient, residential, partial hospitalization, and intensive outpatient treatment. Its superior, industry-leading clinical outcomes, quality of staff and individualized approaches underpin its best-in-class clinical reputation.\n<\/p>\n

\nMatthew Rich, Partner of LLCP, said, \u201cWe are very proud of what Monte Nido has accomplished since we invested in the company. The world-class management team tripled the number of facilities through de novo openings and strategic acquisitions, while never wavering in its commitment to the highest quality treatment and industry-leading clinical outcomes. The business is exceptionally positioned for continued growth, and we wish Candy and the entire management team continued success with their new investor.\u201d\n<\/p>\n

\nCandy Henderson, MS, Chief Executive Officer of Monte Nido, commented, \u201cOur management team is grateful for LLCP\u2019s partnership and guidance throughout our relationship. As a result of their strategic and financial support, Monte Nido has grown significantly, enabling our Company to have a greater impact on the lives of those working toward recovery from eating disorders. LLCP\u2019s management-centric approach has been an important driver of many of our accomplishments, and we are proud to have helped expand access to care to so many patients in need.\u201d\n<\/p>\n

\nThe sale of Monte Nido is LLCP\u2019s eleventh successful exit since the beginning of 2021, following Hand & Stone, Mountain Mike\u2019s Pizza, CJ Fallon, HomeVestors, West Academic, Best Lawyers, Caring Brands, FlexXray, Trinity Consultants and Nothing Bundt Cakes.\n<\/p>\n

\nMonte Nido was an investment of Levine Leichtman Capital Partners Fund V, L.P.\n<\/p>\n

\nHarris Williams served as the lead financial advisor. Kirkland & Ellis LLP and Polsinelli PC served as legal counsel to Monte Nido in connection with the sale.\n<\/p>\n

\nAbout Levine Leichtman Capital Partners<\/b>\n<\/p>\n

\nLevine Leichtman Capital Partners, LLC is a middle-market private equity firm with a 39-year track record of investing across various targeted sectors, including franchising, business and healthcare services, education and engineered products. LLCP utilizes a differentiated Structured Private Equity investment strategy, combining debt and equity capital investments in portfolio companies. This unique structure can provide a less dilutive solution for management teams and entrepreneurs, while delivering growth and income with a significantly lower risk profile.\n<\/p>\n

\nLLCP\u2019s global team of dedicated investment professionals is led by nine partners who have worked at LLCP for an average of 19 years. Since inception, LLCP has managed approximately $13.0 billion of institutional capital across 15 investment funds and has invested in over 100 portfolio companies. LLCP currently manages $9.0 billion of assets and has offices in Los Angeles, New York, Chicago, Charlotte, Miami, London, Stockholm, The Hague and Frankfurt.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMark Semer\/Sara Widmann
\n
Gasthalter & Co.
\n
(212) 257 4170
\n
llcp@gasthalter.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

LOS ANGELES–(BUSINESS WIRE)–Levine Leichtman Capital Partners (\u201cLLCP\u201d), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company Monte Nido & Affiliates (\u201cMonte Nido\u201d or the \u201cCompany\u201d) to funds managed by Revelstoke Capital Partners LLC. Financial terms of the transaction were not disclosed. Founded in 1996, Monte Nido is a leading … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47743","6":"format-standard","7":"category-industry"},"yoast_head":"\nLevine Leichtman Capital Partners Sells Monte Nido - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Levine Leichtman Capital Partners Sells Monte Nido - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"LOS ANGELES–(BUSINESS WIRE)–Levine Leichtman Capital Partners (\u201cLLCP\u201d), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company Monte Nido & Affiliates (\u201cMonte Nido\u201d or the \u201cCompany\u201d) to funds managed by Revelstoke Capital Partners LLC. Financial terms of the transaction were not disclosed. Founded in 1996, Monte Nido is a leading ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T11:02:08+00:00\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Levine Leichtman Capital Partners Sells Monte Nido\",\"datePublished\":\"2022-08-29T11:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/\"},\"wordCount\":521,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/\",\"name\":\"Levine Leichtman Capital Partners Sells Monte Nido - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"datePublished\":\"2022-08-29T11:02:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/levine-leichtman-capital-partners-sells-monte-nido\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Levine Leichtman Capital Partners Sells Monte Nido\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Levine Leichtman Capital Partners Sells Monte Nido - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/","og_locale":"en_US","og_type":"article","og_title":"Levine Leichtman Capital Partners Sells Monte Nido - Pharma Trend","og_description":"LOS ANGELES–(BUSINESS WIRE)–Levine Leichtman Capital Partners (\u201cLLCP\u201d), a Los Angeles-based private equity firm, announced today that it has sold its portfolio company Monte Nido & Affiliates (\u201cMonte Nido\u201d or the \u201cCompany\u201d) to funds managed by Revelstoke Capital Partners LLC. Financial terms of the transaction were not disclosed. Founded in 1996, Monte Nido is a leading ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-29T11:02:08+00:00","author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Levine Leichtman Capital Partners Sells Monte Nido","datePublished":"2022-08-29T11:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/"},"wordCount":521,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/","url":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/","name":"Levine Leichtman Capital Partners Sells Monte Nido - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"datePublished":"2022-08-29T11:02:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/levine-leichtman-capital-partners-sells-monte-nido\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Levine Leichtman Capital Partners Sells Monte Nido"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47743"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47743\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47743"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47743"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}